Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?

Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States

(2021) Vincent Daniels et al.   Human Vaccines & Immunotherapeutics

Real-world Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer

(2021) Susanne K Kjaer et al.   JNCI-Journal of the National Cancer Institute

Cervical Cancer Protection in Japan: Where Are We?

(2021) Asami Yagi et al.   Vaccines

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries

(2020) Marc Brisson et al.   LANCET

Impact of HPV vaccine hesitancy on cervical cancer in Japan: a modelling study

(2020) Kate T Simms et al.   Lancet Public Health

Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan

(2020) Satoshi Nakagawa et al.   CANCER SCIENCE

HPV Vaccination and the Risk of Invasive Cervical Cancer

(2020) Jiayao Lei et al.   NEW ENGLAND JOURNAL OF MEDICINE

Potential for cervical cancer incidence and death resulting from Japan’s current policy of prolonged suspension of its governmental recommendation of the HPV vaccine

(2020) Asami Yagi et al.   Scientific Reports

Epidemiological and clinical analyses of cervical cancer using data from the population-based Osaka cancer registry

(2019) Asami Yagi et al.   CANCER RESEARCH

Outcomes for girls without HPV vaccination in Japan

(2016) Yusuke Tanaka et al.   LANCET ONCOLOGY

Vaccine strategies: Optimising outcomes

(2016) Karin Hardt et al.   VACCINE

HPV catch-up vaccination of young women: a systematic review and meta-analysis

(2014) Elisabeth Couto et al.   BMC PUBLIC HEALTH